Philips Extends Patient Monitoring from Hospital to Home Through Six Partnerships
The Dutch group is expanding its patient surveillance network beyond the hospital bed by integrating wearable technologies and home monitoring solutions from several specialized companies.
Royal Philips (NYSE: PHG, AEX: PHIA) announced on August 6, 2026 new collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree and smartQare. These partnerships aim to integrate wearable technologies and out-of-hospital monitoring solutions into Philips' open monitoring ecosystem.
According to the group, the objective is to help healthcare systems improve the continuity and coordination of care by ensuring connected patient surveillance from hospital to home.
Wearable Devices Integrated into Philips Platform
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The partnerships expand the range of continuous measurements that can be integrated into the Philips ecosystem, including the Patient Information Center (PIC) iX. Blue Spark Technologies provides the TempTraq disposable patch for body temperature monitoring, Caretaker Medical the VitalStream solution for non-invasive blood pressure measurement, and Cuviva a home hospitalization platform.
LifeSignals integrates its UbiqVue multiparametric biosensor, Respiree its 1Bio platform associated with the RS001 sensor, and smartQare its viQtor and Healthdot biosensors for heart rate, respiration, SpO2 and activity monitoring.
Monitoring Extended Beyond Hospital Discharge
These capabilities complement Philips' connected care portfolio, which includes mobile cardiac telemetry (MCOT). This solution enables clinicians to remotely monitor certain cardiac patients for up to 30 days following an evaluation at a facility or emergency department.
These announcements continue the group's recent developments in monitoring, following FDA approval of its reusable pulse oximetry sensor announced in late July 2026.
SectorDispositifs médicaux et optique›Dispositifs médicaux
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: T3 2026
Key reported figures
Revenue: 4 393 millions d'euros
Quarterly revenue: 4 393 millions d'euros
Revenue growth: 2 %
Net income: 27 millions d'euros
Free cash flow: 384 millions d'euros
5 387 millions d'euros
Guidance from the release
« Our year-to-date results, together with our strong order book, give us confidence in delivering our full-year outlook and achieving our medium-term ambitions. » ; « Philips reiterates its full-year 2026 outlook »
Risks mentioned
Macro-economic and geopolitical changes including war in Ukraine and Middle East tensions, plus enacted and proposed tariffs and trade actions
Respironics-related legal proceedings and ongoing investigation by US State Attorneys General excluded from 2026 outlook
Phasing of Ultrasound sales and lower sales in China as previously communicated at Q2
Opportunities identified
Strong demand for latest AI-enabled innovations including new CT platforms Verida and Rembra, ultrasound system Alturion, and HealthSuite Imaging cloud solution
Accelerating innovation in image-guided therapy with EUR 50 million investment in AI, robotics and advanced imaging in Netherlands, plus EUR 150 million in private financing
Extended monitoring partnership with largest US health system through 2034 and expansion of Capsule platform, plus strategic partnerships in China and Latin America
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.